Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Physiomics (PYC) Share News

Physiomics shares drop as laments lack of funding for biotechnology

4th Apr 2023 10:47

(Alliance News) - Physiomics PLC on Tuesday announced that its revenue was hampered by pressure resulting from low biotechnology funding. Read More

AIM WINNERS & LOSERS: Light Science shares plummet on fundraise

4th Apr 2023 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

TRADING UPDATES: Galantas Gold closes placement; Kropz makes draw down

28th Mar 2023 16:46

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Physiomics wins further contract from Bicycle Therapeutics

10th Mar 2023 12:06

Physiomics PLC - London-based oncology consultancy, which uses mathematical models to support the development of cancer treatment regimens and personalised medicine solutions - Gets a further contract from existing client Bicycle Therapeutics relating to an undisclosed programme. Expects this to be completed in Physiomics's current financial year. Read More

EARNINGS SUMMARY: Foxtons profit doubles; Reach yearly profit dips

7th Mar 2023 14:39

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Physiomics COO Chassagnole changes title to chief scientific officer

13th Jan 2023 11:17

(Alliance News) - Physiomics PLC on Friday said Christophe Chassagnole's job title has changed from chief operating officer to chief scientific officer. Read More

Physiomics announces another contract with client Cancer Research UK

11th Jan 2023 12:04

(Alliance News) - Physiomics PLC on Wednesday said it entered into a further contract with its existing client Cancer Research UK to conduct analyses of a blood cancer treatment. Read More

AIM WINNERS & LOSERS: musicMagpie flies; video game shares fall

9th Jan 2023 11:27

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday. Read More

Physiomics shares jump on dosing tool study findings

9th Jan 2023 11:14

(Alliance News) - Physiomics PLC on Monday hailed new opportunities in the emerging personalised dosing space, following the completion of its Partner study. Read More

UK shareholder meetings calendar - next 7 days

15th Nov 2022 15:38

Read More

IN BRIEF: Physiomics shares rise on Ankyra contract extension

10th Nov 2022 14:26

Physiomics PLC - Oncology consultancy based in Oxford, England - Says it has been awarded a further contract by existing client Ankyra Therapeutics. The contract builds on work announced in March, and is expected to complete in the first quarter of 2023. Read More

AIM WINNERS & LOSERS: Manolete swings to loss amid case troubles

10th Nov 2022 10:54

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

AIM WINNERS & LOSERS: Physiomics wins deal; DeepVerge eyes cash raise

12th Oct 2022 11:18

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Physiomics surges on contract win with Cancer Research UK

12th Oct 2022 10:52

(Alliance News) - Physiomics PLC shares jumped on Wednesday after it signed an agreement to work with Cancer Research UK. Read More

IN BRIEF: Physiomics wins third contract from Numab Therapeutics

4th Oct 2022 10:06

Physiomics PLC - oncology consultancy based in Oxford, England - Wins third contract by an existing client, Numab Therapeutics. Says it will use its PKPD modelling capabilities to support the translation of pre-clinical to clinical data with a focus on dose selection. The project is expected to be completed between now and the end of 2022. Read More

EARNINGS UPDATES: Crestchic raises outlook on record year-to-date

29th Sep 2022 15:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

22nd Sep 2022 15:48

Read More

TRADING UPDATES: Michelmersh Brick, Mattioli Woods on-track for growth

7th Jul 2022 16:48

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

IN BRIEF: Physiomics wins new contract for Virtual Tumour platform

8th Apr 2022 11:11

Physiomics PLC - oncology consultancy based in Oxford, England - Wins new contract with Servier Group, an international pharmaceutical company with headquarters in France, to provide specialist mathematical modelling services using Virtual Tumour software platform. This will aid Servier in simulating the effects of immuno-oncology combinations in pre-clinical and clinical settings. The project will complete in the next seven to eight months, the company says. No financial details were provided. Read More

IN BRIEF: Physiomics confident for full-year, in talks for new client

7th Mar 2022 14:55

Physiomics PLC - oncology consultancy based in Oxford, England - Pretax loss widens to GBP170,000 in six months that ended December 31 from GBP132,000 a year before, as revenue stays flat at GBP366,000 from GBP363,000. Notes has contracted revenue of GBP460,000 for the second of its financial year, which ends June 30, and is "well positioned to meet market expectations". Physiomics says it has a strong pipeline of products in advanced discussion, including with a potential new "large pharmaceutical client". Read More

FTSE 100 Latest
Value8,809.74
Change53.53